World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
162
Citations
110135
World Ranking
93
National Ranking
54

Medicine

D-Index
163
Citations
116473
World Ranking
676
National Ranking
390

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Valerie W. Rusch is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their main field of study is Medicine, with a focus on several subfields including Pulmonary and Respiratory Medicine, Surgery, Oncology, Radiology, Nuclear Medicine and Imaging, and Cancer Research.

The scientist's research covers key topics related to lung and thoracic diseases, including:

  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Occupational and Environmental Lung Diseases
  • Pleural and Pulmonary Diseases
  • Esophageal Cancer Research and Treatment
  • Gastric Cancer Management and Outcomes
  • Lung Cancer Research Studies

Frequent co-authors in Valerie W. Rusch's research include:

  • Prasad S. Adusumilli
  • Daniela Molena
  • Kay See Tan
  • David R. Jones
  • James M. Isbell

The scientist has published extensively in several top-tier medical and surgical journals, with frequent publication venues as follows:

  • Journal of Thoracic Oncology
  • Journal of Thoracic and Cardiovascular Surgery
  • The Annals of Thoracic Surgery
  • Annals of Surgery
  • Journal of Clinical Oncology

Notable recent papers authored or co-authored by Valerie W. Rusch include:

  • A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab (2021, Cancer Discovery)
  • The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer (2024, Journal of Thoracic Oncology)
  • Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial (2022, Nature Medicine)
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer (2022, Nature Medicine)
  • COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network (2020, Journal of Thoracic and Cardiovascular Surgery)

Best Publications

  • International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

    William D Travis;Elisabeth Brambilla;Masayuki Noguchi;Andrew G Nicholson

  • EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib

    William Pao;Vincent Miller;Maureen Zakowski;Jennifer Doherty

  • Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network

    Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger

  • The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.

    Peter Goldstraw;Kari Chansky;John Crowley;Ramon Rami-Porta

  • The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

    Peter Goldstraw;John Crowley;Kari Chansky;Dorothy J. Giroux

  • Comprehensive genomic characterization of squamous cell lung cancers

    Peter S. Hammerman;Doug Voet;Michael S. Lawrence;Douglas Voet

  • CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

    Andy Trotti;A.Dimitrios Colevas;Ann Setser;Valerie Rusch

  • Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

    Patrick M. Forde;Jamie E. Chaft;Kellie N. Smith;Valsamo Anagnostou

  • MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

    James Bean;Cameron Brennan;Jin-Yuan Shih;Gregory Riely

  • Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

    Kathy S Albain;R Suzanne Swann;Valerie W Rusch;Andrew T Turrisi

  • Incidence of local recurrence and second primary tumors in resected stage I lung cancer

    Nael Martini;Manjit S. Bains;Michael E. Burt;Maureen F. Zakowski

  • Characterizing the cancer genome in lung adenocarcinoma

    Barbara A. Weir;Barbara A. Weir;Michele S. Woo;Gad Getz;Sven Perner;Sven Perner

  • The IASLC lung cancer staging project: A proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer

    Valerie W. Rusch;Hisao Asamura;Hirokazu Watanabe;Dorothy J. Giroux

  • Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.

    Kathy S. Albain;Valerie W. Rusch;John J. Crowley;Thomas W. Rice

  • Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study.

    Kerby Shedden;Jeremy M.G. Taylor;Steven A. Enkemann;Ming Sound Tsao

  • Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

    Akihiko Yoshizawa;Noriko Motoi;Noriko Motoi;Gregory J Riely;Cami S Sima

  • A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group.

    Valerie W. Rusch

  • 7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction

    Thomas W. Rice;Eugene H. Blackstone;Valerie W. Rusch

  • Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer

    Vincent A. Miller;Mark G. Kris;Neelain Shah;Jyoti Patel

  • Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non–small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial

    Gail E. Darling;Mark S. Allen;Paul A. Decker;Karla Ballman

Frequent Co-Authors

Manjit S. Bains
Manjit S. Bains Memorial Sloan Kettering Cancer Center
Mark G. Kris
Mark G. Kris Memorial Sloan Kettering Cancer Center
Robert J. Downey
Robert J. Downey Memorial Sloan Kettering Cancer Center
William D. Travis
William D. Travis Memorial Sloan Kettering Cancer Center
David R. Jones
David R. Jones Memorial Sloan Kettering Cancer Center
Maureen F. Zakowski
Maureen F. Zakowski Icahn School of Medicine at Mount Sinai
Robert J. Ginsberg
Robert J. Ginsberg Memorial Sloan Kettering Cancer Center
Marc Ladanyi
Marc Ladanyi Memorial Sloan Kettering Cancer Center
Gregory J. Riely
Gregory J. Riely Memorial Sloan Kettering Cancer Center
Harvey I. Pass
Harvey I. Pass New York University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in the healthcare field but unsure if medical school is your next step, there are several alternative online degree options to consider. Nursing remains a highly in-demand and versatile career. Many students find pursuing an easiest nursing schools to get into can offer a practical and rewarding pathway with fewer barriers to entry compared to traditional medical programs.

For current nurses, advancing your credentials through an rn to bsn online cost program can increase your earning potential and expand your career opportunities at an affordable rate. If you're aiming for leadership or academic roles, a phd nursing education online can be a flexible, cost-effective way to reach your goals.

Even those with non-nursing backgrounds can fast-track their entry into healthcare through direct entry nurse practitioner programs for non-nurses online. These programs allow you to leverage previous academic experience and quickly transition to a specialized nursing career. Exploring these related online degrees can open doors to fulfilling roles across the healthcare sector.

Best Scientists Citing Valerie W. Rusch

Trending Scientists

Recently Published Articles